non-human primates
Organism3 papers2 findings
- Animals1
- Cells1
Interventions
1GFD-CD3 bite
downage-related pathology1downcellular senescence1
1 study
GFD-CD3 bite
downage-related pathology1downcellular senescence1
GFD-CD3 bite decreases age-related pathology in non-human primates.
“low-dose GFD-CD3 effectively eliminated senescent cells and alleviated age-related pathologies in aged mice and non-human primates without adverse effects.”
Animalsat low doselow-dose
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates · Aging cell · 29 Sep 2026
GFD-CD3 bite decreases cellular senescence in non-human primates.
“low-dose GFD-CD3 effectively eliminated senescent cells and alleviated age-related pathologies in aged mice and non-human primates without adverse effects.”
Animalsat low doselow-dose
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates · Aging cell · 29 Sep 2026
Latest
3Ferro-aging: iron-lipid axis in systemic decline
Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease
The three-dimensional cell platform maintains biological aging markers while spontaneously developing hallmark pathologies of sporadic Alzheimer disease.
bioRxiv · Alsolami S et al.
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates
Monitored by serum transaminase levels, low doses of the drug alleviated age-related pathologies without causing the hepatotoxicity seen at higher doses.
Aging cell · Deng J et al.